Notizie e Video - ALPINE GROUP INC - Pagina 2

DAYTONA BEACH, Fla., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (the “Company” or “PINE”) announced today that it has priced its initial public offering of 7,500,000 shares of common stock at an initial public offering price of $19.00 per share. The Company has granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. Settlement of...

Alpine 4 Technologies (ALPP) Reports Q3 2019 Revenue Growth of 63% over Q3 2018 PR Newswire PHOENIX, Nov. 19, 2019 PHOENIX , Nov. 19, 2019 /PRNewswire/ -- Alpine 4 Technologies (OTCQB: ALPP) announced today Q3 2019 revenue of $7.08 million , an increase of 63% over Q3 2018 revenue. Kent B. Wilson , Alpine 4 CEO, had this to say: " Q3's numbers delivered on Alpine 4's planned growth for 2019. I would like to personally say thank you to all of our employees at Quality Circuit Assembly, American...

...

...

Alpine 4 Technologies, Ltd. (ALPP) Reveals its Latest Acquisition, Deluxe Sheet Metal, Inc PR Newswire PHOENIX, Nov. 8, 2019 PHOENIX , Nov. 8, 2019 /PRNewswire/ -- Alpine 4 Technologies (OTCQB:ALPP) continued its acquisition strategy today with the announcement that it has entered into a purchase of Deluxe Sheet Metal, Inc. (DELUXE) of South Bend, Indiana. This acquisition adds to Alpine 4's Construction Services portfolio which began in 2019 with its purchase of Morris Sheet Metal, Corp....

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer, autoimmune/inflammatory, and other diseases, today presented new preclinical data on ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of advanced malignancies, at The Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting. ALPN-202 is Alpine’s lead oncology program and remains on track to initiate a...

...

...

...

...

...

...

...

...

...

Alpine 4 Technologies (ALPP) Expects to Report Q3 2019 Revenue Growth of 43% over Q3 2018 PR Newswire PHOENIX, Oct. 9, 2019 PHOENIX , Oct. 9, 2019 /PRNewswire/ -- Alpine 4 Technologies (OTCQB: ALPP) announced today that it is providing preliminary guidance for its Q3 2019 sales. The company expects to report for the period ending Q3 2019 sales of $6.9 million which is revenue growth of approximately 43% over Q3 2018. Alpine 4 also is estimating for the first 9 months of 2019 that its revenue...

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer, autoimmune/inflammatory, and other diseases, today announced planned poster presentations at upcoming scientific meetings highlighting new preclinical data on the Company’s lead programs: ALPN-101, a first-in-class dual CD28/ICOS inhibitor for the treatment of autoimmune diseases, and ALPN-202, a conditional CD28 costimulator and dual checkpoint...

Stefano Glassier conosce il Monte Bianco come le sue tasche, per la montagna ha venerazione e rispetto. 'L'ambiente è l'unica e vera ricchezza'… ALTRE ......

BOSTON, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Alpine Bearing today announced that the ball bearing distributor has earned its ISO 9001: 2015 certification at its Boston facility. The Alpine West facility in Anaheim, California was ISO 9001: 2015 certified in 2018 and is also AS 9100D certified. ISO 9001 is the international standard that specifies requirements for a quality management system (QMS). Certified organizations demonstrate the ability to consistently provide products and services that...

Alpine 4 Technologies, Ltd. (ALPP) Announces the Date for Its 2019 Alpine 4 Expo and Shareholder Meeting PR Newswire PHOENIX, Sept. 18, 2019 PHOENIX , Sept. 18, 2019 /PRNewswire/ -- Alpine 4 Technologies (OTCQB: ALPP) announced today it will be holding the company's 4th Annual Shareholder Meeting on Saturday, November 23, 2019 , from 1:00 pm- 3:00 pm . The meeting will take place at ASU's SkySong Innovation Center located at 1475 N Scottsdale Rd. Scottsdale, AZ 85257 in rooms Synergy I and...